Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

Clinical trial NCT04499053 · RECRUITING

Trial details

NCT number: NCT04499053
Sponsor: Georgetown University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung

Start date: 2020-12-09
Primary completion: 2027-02-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.